• 1
    Kim IH, West CE, Kwatra SG et al. Comparative efficacy of biologics in psoriasis: a review. Am J Clin Dermatol 2012; 13:36574.
  • 2
    Lin VW, Ringold S, Devine EB. Comparison of ustekinumab with other biological agents for the treatment of moderate to severe plaque psoriasis: a Bayesian network meta-analysis. Arch Dermatol 2012; 148:140310.
  • 3
    Puig L, Lopez A, Vilarrasa E et al. Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points. J Eur Acad Dermatol Venereol 2013; doi: 10.1111/jdv.12238 (Epub ahead of print).
  • 4
    Leidy NK, Vernon M. Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. Pharmacoeconomics 2008; 26:36370.
  • 5
    Speight J, Barendse SM. FDA guidance on patient reported outcomes. BMJ 2010; 340:c2921.
  • 6
    U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaulation and Resarch; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006; 4:79.
  • 7
    Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 2005; 8(Suppl. 1):S924.
  • 8
    Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 2004; 7:20415.
  • 9
    Barbosa CD, Balp MM, Kulich K et al. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence 2012; 6:3948.
  • 10
    Renzi C, Tabolli S, Picardi A et al. Effects of patient satisfaction with care on health-related quality of life: a prospective study. J Eur Acad Dermatol Venereol 2005; 19:71218.
  • 11
    Delestras S, Roustit M, Bedouch P et al. Comparison between two generic questionnaires to assess satisfaction with medication in chronic diseases. PLoS ONE 2013; 8:e56247.
  • 12
    Vender R, Lynde C, Gilbert M et al. Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practice. J Cutan Med Surg 2012; 16:40716.
  • 13
    Driessen RJ, Bisschops LA, Adang EM et al. The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics. Br J Dermatol 2010; 162:13249.
  • 14
    Callis Duffin K, Yeung H, Takeshita J et al. Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. Br J Dermatol 2014; 170:67280.
  • 15
    Nast A, Boehncke WH, Mrowietz U et al. [S3-guidelines for the treatment of psoriasis vulgaris. Update 2011]. J Dtsch Dermatol Ges 2011; 9 (Suppl. 2):S1104 (in German).
  • 16
    Nast A, Boehncke WH, Mrowietz U et al. [S3-guidelines on the treatment of psoriasis vulgaris (English version). Update]. J Dtsch Dermatol Ges 2012; 10 (Suppl. 2):S195.
  • 17
    Pathirana D, Ormerod AD, Saiag P et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (Suppl. 2):170.
  • 18
    van Lumig PP, Driessen RJ, Kievit W et al. Results of three analytical approaches on long-term efficacy of etanercept for psoriasis in daily practice. J Am Acad Dermatol 2013; 68:5763.
  • 19
    Pope J, Thorne JC, Haraoui BP et al. Do patients with active RA have differences in disease activity and perceptions if anti-TNF naive versus anti-TNF experienced? Baseline results of the optimization of adalimumab trial. Med Sci Monit 2012; 18:PI1720.
  • 20
    Armstrong AW, Robertson AD, Wu J et al. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003–2011. JAMA Dermatol 2013; 149:11805.
  • 21
    Christophers E, Segaert S, Milligan G et al. Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study. J Dermatolog Treat 2013; 24:1938.
  • 22
    van Cranenburgh OD, de Korte J, Sprangers MA et al. Satisfaction with treatment among patients with psoriasis: a web-based survey study. Br J Dermatol 2013; 169:398405.